Dual-Mode Immunoassay Structure for Accurate PSA Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current prostate cancer detection methods suffer from long turnaround times, cumbersome procedures, and low detection accuracy, and there is a lack of dual-mode detection technologies combining Surface-Enhanced Raman Scattering (SERS) and upconversion luminescence for enhanced sensitivity and accuracy.
Innovation Solution
A dual-mode immunoassay structure using a titanium carbide SERS substrate and rare-earth doped sodium yttrium fluoride nanoparticles, integrating SERS for high sensitivity and molecular fingerprinting with upconversion luminescence for strong anti-interference capability, utilizing a titanium carbide/molybdenum disulfide composite and NaYF4:Yb,Er immunoprobe for cancer biomarker detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional detection methods are used for PSA, then the detection process is simple, but the detection accuracy and sensitivity are low
Solution Approach 1:
The patent combines SERS substrate and upconversion luminescent nanoparticles into a dual-mode detection system. The SERS substrate provides high sensitivity and molecular fingerprinting capability, while the upconversion luminescent nanoparticles provide strong anti-interference capability. This merging of two different detection mechanisms into a single assay system resolves the contradiction by achieving high detection accuracy without requiring completely separate complex detection systems.
Solution Approach 2:
The patent uses a composite structure consisting of a titanium carbide SERS substrate combined with rare-earth doped sodium yttrium fluoride upconversion luminescent nanoparticles. This composite material approach allows the system to simultaneously utilize the advantages of both SERS (high sensitivity) and upconversion luminescence (anti-interference capability), thereby improving detection accuracy while maintaining a unified detection platform.
2Productivity
If conventional immunoassay procedures are used, then the operation is straightforward, but the turnaround time is long and procedures are cumbersome
Solution Approach 1:
The patent replaces conventional mechanical/chemical immunoassay procedures with optical detection methods. Instead of relying on traditional colorimetric or chemiluminescent readings that require complex washing and incubation steps, the system uses SERS spectroscopy and upconversion luminescence imaging to directly detect and quantify PSA. This substitution of detection mechanisms significantly reduces the number of operational steps and accelerates the turnaround time while maintaining ease of operation through standardized sampling and reading procedures.
3Measurement precision
If single-mode detection is used, then the system is simple, but the detection sensitivity and accuracy are limited
Solution Approach 1:
The patent merges SERS and upconversion luminescence detection modes into a single dual-mode detection system. The SERS substrate provides high sensitivity and molecular fingerprinting capability, while the upconversion luminescent nanoparticles provide strong anti-interference capability. This merging allows the system to achieve enhanced detection sensitivity without requiring completely separate detection systems, as both modes can be utilized within a single assay framework.
Solution Approach 2:
The dual-mode detection system is designed to perform multiple detection functions simultaneously. The same assay platform can utilize both SERS spectroscopy for high-sensitivity detection and upconversion luminescence imaging for anti-interference capability, making the system universal for various detection requirements. This multi-functionality allows the system to adapt to different detection needs while maintaining high sensitivity and accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dual-mode immunoassay structure significantly enhances cancer detection accuracy and sensitivity, providing a simple, low-cost method suitable for widespread clinical application, with detection limits as low as 10−6 mg/mL for prostate cancer biomarkers.
Implementation Method 1
Surface-Enhanced Raman Scattering (SERS), as an efficient spectroscopic detection technique, offers extremely high detection sensitivity and molecular fingerprinting capabilities
Implementation Method 2
Upconversion luminescent materials, which are anti-Stokes phosphors, are materials that emit visible light upon excitation with near-infrared light
Data Source
AI summary
A dual-mode immunoassay structure includes a titanium carbide/molybdenum disulfide composite immunoassay substrate and a NaYF4:Yb,Er immunoprobe, wherein the NaYF4:Yb, Er comprises 78% Y, 20% Yb, and 2% Er. The method of preparation includes the steps of: (S10) preparing titanium carbide powder via an acid-etching method; (S20) fabricating the titanium carbide/molybdenum disulfide composite immunoassay substrate; and (S30) preparing the NaYF4:Yb,Er immunoprobe. The dual-mode immunoassay structure is suitable for use in the detection of prostate cancer, providing both Surface-Enhanced Raman Scattering (SERS) and upconversion luminescence signals for analysis, rendering it applicable for clinical diagnostics.